NEW YORK (GenomeWeb) – Exosome Diagnostics today announced that it has raised $60 million in a Series B round of financing.

Participating investors included Forbion Capital Partners, NGN Capital, and CD Ventures. Qiagen, Arcus Ventures, Tiger Management, and Blue Ridge Capital participated as new investors in the company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more